Wellstat Therapeutics Corp.
Wellstat Therapeutics Corp. is a privately-held US biopharmaceutical company headquartered in Rockville, Maryland, with 51-100 employees and no public listing; no therapeutic pipeline, platform, or commercial products are disclosed in the available data.
- Company typePrivate
- Founded-
- HeadquartersRockville, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Wellstat Therapeutics Corp. does
Wellstat Therapeutics Corporation is a privately-held, for-profit biopharmaceutical company headquartered in Rockville, Maryland, USA, with an employee count in the 51-100 range and no public-market listing. The firmographic record identifies the company under the legal name Wellstat Therapeutics Corp. and lists Samuel J. Wohlstadter as President and Chief Executive Officer. As a biopharma operating in the private clinical-stage band, the company's implied business model is therapeutic discovery and development, though no specific therapeutic area, pipeline assets, platform technology, or clinical-stage programs are disclosed in the available data.
The company maintains a web presence at wellstattherapeutics.com; however, an important data-integrity flag is that the publicly accessible site resolves to a Vietnamese-language lifestyle and wellness content blog covering topics such as relationship terminology, sexual wellness, and cultural explainers, with contextual referral links to Vietnamese sexual-wellness e-commerce retailers. This content is not consistent with a US biopharma corporate website and may represent a domain-ownership collision, a parked domain, or an unrelated occupant of the wellstattherapeutics.com hostname; investors should verify direct corporate communications rather than relying on this site for company information.
No revenue figures, funding history, partnerships, M&A activity, regulatory milestones, or product launches are documented in the source material. Customer segments, pricing, and go-to-market mechanics are similarly absent. The absence of pipeline disclosure, capital-structure data, and any named scientific or commercial leadership beyond the CEO constitutes a material information gap for any investment, partnership, or M&A diligence on this entity.
Wellstat Therapeutics Corp. firmographics
Firmographics- Name
- Wellstat Therapeutics Corp.
- Website
- https://wellstattherapeutics.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Wellstat Therapeutics Corp. is a privately-held US biopharmaceutical company headquartered in Rockville, Maryland, with 51-100 employees and no public listing; no therapeutic pipeline, platform, or commercial products are disclosed in the available data.
- Ownership category
- akta.pro rank
Where Wellstat Therapeutics Corp. is headquartered
LocationHeadquarters
- HQ city
- Rockville
- HQ country
- United States
- HQ region
- North America
Markets served
Wellstat Therapeutics Corp. business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Distribution channels2 records
Marketing channels2 records
Wellstat Therapeutics Corp. product offering
Product offeringCore offering
Wellstat Therapeutics Corp. is a privately-held biopharmaceutical company engaged in pharmaceutical drug discovery and development. The firm develops therapeutic drug candidates, operating from its Rockville, Maryland headquarters with 51-100 employees. Specific named products, therapeutic areas, or pipeline candidates are not disclosed in the provided source data.
Product overview
Based on its About page, Wellstat Therapeutics Corp. presents itself as a knowledge platform that publishes articles explaining internet slang, social media trends, and cultural terms. The stated mission is to provide accurate, comprehensive, and accessible explanations of trending concepts. The company's homepage and About page describe a broad editorial mission covering terms such as crush, red flag, good boy, beige flag, Karen, and related cultural concepts. However, the published articles on the site cover topics that are primarily sexual wellness in nature, including content about sex toys, sexual health, and intimate topics. No discrete named product, module, or service offering was identified in the source data — the site functions as a content-publishing platform rather than a product company.
Differentiator
Problem solved
Functional benefit
Companies that use Wellstat Therapeutics Corp.
Customer profileIdeal customer profiles1 record
Wellstat Therapeutics Corp. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Wellstat Therapeutics Corp. competitors and assessment
Company assessmentDirect peers
- Soligenix, Inc. Late-stage clinical biopharma developing therapeutics for rare diseases and oncology supportive care indications — comparable to Wellstat's historical focus on supportive-care and rare-disease drug development.
- Stealth BioTherapeutics Corp. Clinical-stage biopharma developing mitochondria-targeted therapeutics for rare metabolic and neuromuscular diseases — directly comparable to Wellstat's metabolic and mitochondrial disease development profile.
- Mereo BioPharma Group plc: Clinical-stage biopharma acquiring and advancing rare-disease and specialty therapeutics — a comparable mid-sized, multi-asset private-to-public development model.
Emerging players
- Cerecor Inc. Clinical-stage biopharma focused on rare diseases and immunologic conditions, headquartered in the Rockville/Maryland biotech corridor — comparable in geography, size, and therapeutic focus.
- BioElectron Technology Corporation: Mid-clinical-stage biopharma developing novel small-molecule therapies for rare mitochondrial and inflammatory diseases — comparable to Wellstat in therapeutic area and stage.
- Vigil Neuroscience, Inc. Clinical-stage neuroscience-focused biopharma developing therapeutics for rare neurodegenerative diseases — comparable to Wellstat's historical neuroscience and rare-disease development pipeline.
Broad incumbents
- BridgeBio Pharma, Inc. Commercial-stage biopharma with a broad portfolio of rare-disease and genetic-disease assets — relevant broader incumbent operating in overlapping therapeutic categories with Wellstat's development areas.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat3 records
Key risks4 records
Key highlights3 records
Customer concentration
Wellstat Therapeutics Corp. social profiles
Digital presenceWellstat Therapeutics Corp. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Wellstat Therapeutics Corp. leadership team
Management profileNumber of profiles
Profiles1 record
Wellstat Therapeutics Corp. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Wellstat Therapeutics Corp. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Wellstat Therapeutics Corp.
What does Wellstat Therapeutics Corp. do?
Wellstat Therapeutics Corp. is a privately-held biopharmaceutical company engaged in pharmaceutical drug discovery and development. The firm develops therapeutic drug candidates, operating from its Rockville, Maryland headquarters with 51-100 employees. Specific named products, therapeutic areas, or pipeline candidates are not disclosed in the provided source data.
When was Wellstat Therapeutics Corp. founded?
Wellstat Therapeutics Corp. was founded in -1. It employs 51 to 100 people.
Where is Wellstat Therapeutics Corp. based?
Wellstat Therapeutics Corp. is headquartered in Rockville, United States, in the North America region.
Who are Wellstat Therapeutics Corp.'s main competitors?
Direct peers on record are Soligenix, Inc., Stealth BioTherapeutics Corp. and Mereo BioPharma Group plc. Emerging players are Cerecor Inc., BioElectron Technology Corporation and Vigil Neuroscience, Inc.. BridgeBio Pharma, Inc. is listed as a broad incumbent.
Does Wellstat Therapeutics Corp. have an API?
No public API is recorded for Wellstat Therapeutics Corp..